Additional than ever, Connecticut inhabitants are looking to age at residence. Can the condition hold up with a growing home wellness treatment market that has been unregulated so considerably?
WSHU’s Ebong Udoma spoke with CT Mirror’s Dave Altimari to talk about the post he wrote with Jenna Carlesso, “Home treatment suppliers: A developing but unregulated field,” as part of the collaborative podcast Very long Tale Shorter.
You can browse their story here.
Episode Transcript
WSHU: We’ve viewed a shift away from nursing homes or lengthy-phrase treatment facilities as extra individuals choose to age at dwelling. But you say there may be a difficulty, mainly because residence care companies are not properly supervised by the condition. And you give the instance in your post about 92-year-outdated Ruth Hughes of Farmington who was ripped off by mom and daughter group property treatment suppliers Cynthia Williams and Sharonda Williams, could you convey to us a little bit a lot more about them and this certain instance in this article?
DA: Sure. So the dwelling companion agency industry is the only point in healthcare that is not overseen by the Office of Community Wellbeing. It is the Department of Client Defense at the moment that is dependable for investigating them. And there’s quite minimal that is finished to track who’s functioning for these providers. The firms are meant to do track record checks, but they do not have to offer them to the condition. In the scenario you are referencing, what happened was, I did a Freedom of Facts request to get three many years truly worth of DCP investigations. And there had been over a 50 {1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} a dozen of them in which a personal treatment aide stole the cash from the customer.
In the situation that you’re referring to, Ruth was in an assisted residing facility. She experienced employed a corporation to have an aide arrive and remain with her a several hrs a working day. And about a thirty day period immediately after the human being had started off performing there, her conservator got a phone from the lender inquiring about $27,000 worthy of of checks that experienced been prepared off Ruth’s checkbook. The conservator right away understood that that wasn’t the variety of funds that Ruth would be investing and went to the Farmington law enforcement to do an investigation and they determined that the PCA, her title was Cynthia Williams, was mainly writing checks to purchase furnishings for her condominium and experienced invested just about $27,000 producing all these checks. When the police started investigating, they realized there was a next consumer that she was also thieving from. They inevitably arrested the two the mom and daughter on larceny fees. And each of them ended up pleading responsible in Harford court docket.
WSHU: But which is just one case in point. And it’s not just fraud we’re chatting about here. You have a different instance of an 86-calendar year-previous shopper in Waterbury whose dwelling treatment assistant ended up overdosing in his condominium. And he was by himself.
DA: That was a South Windsor case. The Waterbury scenario was the just one in which when the guy died, he was 89 decades aged, the PCA refused to allow the household into the apartment saying that they experienced a relationship and had to get the law enforcement associated and DCP and it took six-8 weeks for them to even get access to the father’s stuff.
The scenario you are referring to occurred in South Windsor. A gentleman struggling from dementia, usually him and his PCA would choose a bus to a senior middle. So the bus driver understood who he was and realized we usually experienced a PCA with him. So when he confirmed up a single early morning with out his PCA, they essentially did not allow him on the bus and left him on the aspect of the road. The male had no thought of how to get home. He was described lacking to the law enforcement. They sooner or later observed him about an hour following he experienced been reported missing. And when they introduced him back again to the home, they observed that his PCA had overdosed on heroin and died in the household. And the man had just walked out and walked to the bus station and then experienced walked around the community. Thankfully the police found him comparatively rapidly.
WSHU: So what is been done about this? I imply, is the state accomplishing a little something, are lawmakers seeking into this?
DA: Indeed, in fact. As we have been reporting on this series, the legislature formed a Home Companion Job Drive to consider a look at what DCP was doing, what was the oversight, and what could be performed in different ways. And they have a invoice that’s handed out of committee that would transfer the duty of overseeing these services from DCP to DPH.
WSHU: The sensation is that DCP is much too lenient, or DCP does not have the capacity to properly regulate this industry? That it is improved carried out by the Section of General public Health?
DA: DCP does not have the manpower, the selection of property companion businesses has gone from 300 to 900 in just a few a long time. DCPS investigative unit is down to like a few persons, one supervisor and two investigators, so they just really do not bodily have the bodies to do investigations. The kinds they do are inclined to emphasis more on factors like firms that mis-promote their products and services, and assert that they can do health care processes like clean up wounds or modify IVs, when they are genuinely not intended to do that kind of things. They emphasis additional on that than they do on who’s doing the job in these spots.
And DCP does have a tendency to generally situation reasonably compact fines when they do come across a firm has done a little something incorrect. And their argument there is that as opposed to with nursing residences, where DPH can place a receiver in and can get over a nursing residence. DCP simply cannot do that. So if they shut down a home companion agency because someone was stealing from a customer, they would shut the full agency down. All the men and women who are getting expert services by that agency are going to be left in the lurch.
WSHU: But do you also say listed here that the Office of Public Wellness is saying that they’re not ready to choose this on appropriate away.
DA: They also are down a whole lot of folks who’ve retired. their unit that investigates nursing households would likely be the unit that would acquire this about. And I believe what the general public wellbeing commissioner informed the committee and I’m absolutely sure what she will notify the full legislature is that if you want us to do that, we’re likely to require a substantial boost in funding so that we can seek the services of investigators exclusively to offer with this kind of agency.
WSHU: I noticed anything you described in the post, about a billion bucks is necessary to spend on regulating this market in the in the vicinity of potential?
DA: Three matters heading on. Number a single, the point out is by now putting additional cash into household health care, they have sped up a system that had now started out ahead of COVID. And the greater part, ultimately, about 75{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of Medicaid cash that the condition gets will likely go to dwelling health and fitness treatment rather than nursing houses. The other problem is just like nursing households and hospitals, household wellness treatment organizations are getting a challenging time finding staff. It is not a great paying out career. It’s not simple function. And so that’s a big difficulty. So we’d have more people seeking for residence wellbeing care, much less folks performing in the industry. How do you tackle that? Chatting about needing to maximize salaries potentially or come up with much better advantages or improved spend deals to get people today into the subject?
WSHU: A great deal of particular treatment aides have joined a union, SEIU 1199. Would that help, the point that it is been unionized now, would that enable in seeking to control this market?
DA: A person of the difficulties with the whole agency is it is a really confusing issue to navigate. The PCA’s you’re referring to as members of the union, they actually are licensed by the Office of General public Wellbeing presently, so they can deliver a larger stage of care than what the property companions can. The home companions are an individual who is heading to arrive about, prepare dinner your meals, clean your dresses, and do your banking for you. They’re not caring for your wounds. So that is a various degree, the PCAs that are unionized are compensated more than home companion agencies. The trouble with the PCA is that there’s once more, there is not sufficient of them and the procedure that the point out has set up, it is incredibly tricky to discover. It is generally a paper booklet that they set out that has names of PCAs and the listing is previous. The point out desires to do a far better job of acquiring online sites. And proper now, they really do not have that and it’s a pretty difficult discipline to navigate.
WSHU: Something interesting in your posting, a few of several years back, Senator Saud Anwar tried to put ahead legislation that would have demanded a drug test for home companions, but there was a large amount of pushback from the house companion companies. What was the purpose for that?
DA: That was following the South Windsor case exactly where the aide overdosed in the household, there have been a few points that they were being proposing there. The one that did get handed was a necessity that a federal qualifications check out be carried out on each and every staff that an HCA hires, the trouble there is that the state nonetheless does not call for the businesses to switch that in excess of to the condition. So DCP has no strategy who is working at any of these areas, and no matter if they’ve experienced a appropriate background check out performed.
What you are referring to is right after the aid overdosed in the South Windsor scenario, they wished to move laws to make it a need to move a drug test and get a work. And the pushback on that was the value of the tests. HCA didn’t want to decide up the price of owning to pay out for drug tests for all people that they hired. And in the end, that did not make it into the bill.
WSHU: So is the condition likely to be able to grapple with this, as you know, you say listed here, the projections are that by 2040, there’ll be a 30{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} improve in the selection of men and women who are choosing to age at property, who will want this care. So it’s a growing population. It’s a increasing need to have. And we feel to be quite much driving where by we have to have to be as considerably as regulating that sector.
DA: I consider we’re very considerably guiding on regulating it, but also on funding healthcare, in general, but in certain aged care services. And which is a issue the legislature is, I feel, this session for the to start with time is genuinely wrestling with. I’m curious to see what receives passed this session, what type of funding comes with some of these payments that are at this time getting mentioned. Mainly because that is ultimately going to say, what comes about in this article.
How significantly money is the condition prepared to set into what is likely to be a growing trouble? The range that you ended up speaking about, the projections are quicker than even the state originally projected with this and where by this. I feel Connecticut is the sixth oldest point out in the nation proper now, and receiving older. So this is a challenge that is only gonna get even worse until it will get dealt with. And I consider we’ll see how it performs out. But I believe this is the to start with time I do feel the legislature sees that this is a major problem likely forward, and appears keen to maybe set additional income into it.
When the bank manager called Irene Loretto and told her that her 92-year-old friend Ruth Hughes, who suffered from dementia and lived in a Farmington assisted living facility, tried to cash $27,000 worth of checks andbought a $3,000 bedroom set, she knew something was amiss.
Loretto, who had been granted power of attorney for her friend, immediately called Farmington police because she knew Hughes would not have spent that much money.
During a seven-month investigation, Farmington police discovered that Hughes’ home care aide had not only stolen her identity but also that of another client living at a nursing home in Farmington and had cashed at least 20 ofher clients’ checks, totaling nearly $40,000, according to police reports.
They charged a mother-daughter team of Cynthia Williams and Sharonda Williamswith first-degree larceny and forgery, among other charges, according to court documents and news reports. Both women eventually pleaded guilty in Hartford Superior Court and received suspended jail sentences.
Loretto was shocked to learn from Farmington police that Cynthia Williams had a previous conviction for fourth-degree larceny in 2017 after an arrestby Hartford police.She called Williams’ employer, Brightstar Care, and asked why they had hired someone with a criminal record to work with older adults and people with disabilities. Brightstar did not respond to several requests for comment from the CT Mirror.
“I asked them, ‘Didn’t you check her background at all before assigning her to work with a 92-year-old woman?’” Loretto said. “They told me they did and didn’t find anything. Well, they didn’t look too hard. It was my mistake to assume that they checked people out.”
Cases like Hughes’ are an example of the challenges policymakers face as they attempt to “right size” the state’s elder care services by pivoting from long-term care facilities to expanding options for people to receive care at home.By 2040, state leaders expect a nearly 30{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} increase in the number of long-term care residents on Medicaid who remain in their homes, and they’ve committed more than $1 billion annually to that cause.
The shift has exposed a home care industry that operates with little oversight, is hard for consumers to navigate, and has a dire shortage of chronically underpaid workers.
One element of the sprawling home care industry is homemaker companion agencies (HCAs), which are overseen by the state Department of Consumer Protection. Unlike nursing home employees and home health aides, who must be licensed by the state Department of Public Health, there is no licensing process for HCA workers. Instead, homemaker companion agencies must register annually with DCP.
Managers at the companies are required to conduct criminal background checks on prospective employees but aren’t required to share that information with DCP, which does not track who works at the more than 900 HCAs registered with the state.
The result is an industry that some elder care experts refer to as the “wild west,” because there is little oversight, unlike long-term care facilities, which are heavily regulated by the state Department of Public Health.
The CT Mirror reviewed more than 75 complaints against homemaker companion agencies filed with the consumer protection department between 2018 and 2020 and discovered at least half a dozen cases in which HCA employees were arrested for allegedly stealing from their clients, more than a dozen findings by DCP investigators of agencies that routinely mis-advertised the services they provided, and seven complaints of clients being left alone for hours at a time.
The complaints against the companion agencies are varied and troubling.
There’s the 2019 Shelton case where apersonal care aidewas accused of stealing more than $20,000 from her 83-year-old client. There’s the Waterbury family who couldn’t get their father’s aide to leave after he died inMarch 2018 because she claimed she had been in a relationship with the 88-year-old stroke victim. There’s the East Hartford man with dementia who tried to board a bus while wandering the neighborhood after his live-in aide overdosed on heroin. And there’s the Cromwell woman who realized her aide had rented and furnished an apartment using her stolen checkbook.
The Mirror’s review of the DCP investigations found that many either led to small fines of less than $5,000 or an employee being fired.
DCP spokeswoman Kaitlyn Krasselt acknowledged that the agency has never denied a homemaker companion business’s registration and has never revoked a business’s registration following an investigation.
“It’s not the goal to close them down,” Krasselt said. “It is to bring them into compliance so that families aren’t left without the care that they rely on.”
She said state statutes don’t allow DCP to take over a company like DPH can do with a nursing home by placing it in receivership.
Sen. Patricia Billie Miller said DCP is too lenient on the agencies.
Senator Pat Billie Miller thanks Rep. Robyn Porter, D-New Haven, after being sworn in as the new state Senator for the 27th District representing parts of Stamford and Darien. Yehyun Kim / ctmirror.org
“The way it stands now, you can basically get a certificate … and I think there are potentially bad actors out there that would harm our seniors or take advantage of our older adults,” said Miller, a Democrat from Stamford.
“This is an industry that needs to be looked at a lot more closely, because we’re an aging population. I think there needs to be some policies and regulations in place to protect them,” she said.
Kicked to the curb
The voice mail message left on the morning of June 12, 2019,stunned Alma Hernandez.
Her 86-year-old father, who has dementia, tried to get on a bus in South Windsor without his caregiver and was escorted off because he didn’t have a ticket, the bus company representative said. Hernandez said her father and his home care aide rode the bus to go to a community center several times a week, so the drivers were familiar with him and knew he shouldn’t travel alone.
“They left him alone on the sidewalk, so where was he? And where was his live-in aide that was supposed to be with him?” Hernandez said.
She called the police, who soon found her father wandering around the neighborhood. When police took him home, they discovered his aide comatose in the apartment. Hernandez said the aide died on the way to the hospital of a suspected overdose and that police found drugs in the apartment.
Police told her thehome care aide had previous drug convictions, Hernandez said, so she called Companions Forever to ask why they hadn’t drug-tested their employee, given his history. Hernandez said in her complaint to DCP that Companions Forever told her they weren’t required to perform drug tests and that they had no knowledge of their employee’s previous drug charges. Companions Forever did not respond to requests for comment from the CT Mirror.
“I wonder how many people assume that they require people to get drug tested before they put them with their loved ones or don’t know what type of background check, if any, they even do,” Hernandez said.
So Hernandez decided to act.
She contacted state Sen. Saud Anwar, D-South Windsor, and asked him to sponsor legislation that would require homemaker companion agencies to test prospective employees for drugs. She also asked him to submit a bill making bus drivers mandatory reporters if they see abuse or neglect.
“My father got on that bus every day to go to the senior center, and he always had his aide with him, so they knew him and should have realized something wasn’t right that he was by himself and not kicked him to the curb,” she said.
The mandatory reporter bill passedin 2021, butdrug testing legislation died after the HCAs told lawmakers it would be too expensive, given their high employee turnover. They also objected to legislation that would have required them to pay for an FBI background check for every employee, arguing it wasn’t cost effective, but legislators passed it anyway.
The updated law included a requirement that HCAs perform national background checks and “recommended” they hire an outside company that specializes in doing them. Previously, DCP did not place parameters on what type of background search agencies did.
DCP officials acknowledged they have no idea whether the HCAs are actually performing the background checks unless they get a complaint or randomly audit the company.
Massive growth
During that same legislative session, lawmakers — recognizing the oversight problems in the rapidly growing homemaker companion sector — established a task force to study and recommend long-term solutions.
Miller, a former co-chair of the Aging Committee, helped pass legislation establishing the Homemaker Companion Task Force that began meeting last September.
The task force recently submitted a 26-page report to the Aging Committee, which used it as the basis of a bill that went to a public hearing in February and drew more than 40 comments, nearly all of which were favorable.
The task force’s most significant recommendation — transferring oversight of HCAs from consumer protection to the public health department by July 1, 2024 — was adopted and approved by the Aging Committee despite concerns raised by officials from both agencies.
The bill also requires the DCP commissioner to revoke a certificate of registration if an agency violates certain provisions three times in one calendar year, to create a guide that details how to file a complaint against a homemaker-companion agency, and to develop a plan to implement mandatory training standards for agency employees.
But in written testimony submitted for the public hearing, DPH Commissioner Manisha Juthani said her agency would need more time before assuming oversight of the HCAs. The commissioner requested an extra year for the takeover and said DPH’s approach to regulating the HCAs would be different from consumer protection’s.
Public Health Commissioner Manisha Juthani. Juthani, MD, an associate professor of medicine at Yale School of Medicine and of epidemiology at Yale School of Public Health. Yehyun Kim / ctmirror.org
“A significant information transfer between DCP and DPH would be required to fully understand the scope of the registration and monitoring process already in place,” Juthani wrote. “Additionally, given the differences in responsibility and subject matter expertise at DCP and DPH, the process that DPH would use to regulate and monitor the Homemaker Companion Agencies would be different from what DCP currently monitors. While DCP’s focus lies more in monitoring business practices, DPH would focus on the health and safety of the services provided by Homemaker Companion Agencies.”
One of the task force members was Leslie O’Brien, a legislative liaison for the consumer protection department, who acknowledged the growing homemaker companion industry is overwhelming the department.
“We’re really struggling at DCP to figure out how to manage the massive growth in this industry with what the statutory constraints are, while recognizing that the most important thing is protecting consumers and ensuring public health and safety,” O’Brien said during a presentation to the Homemaker Task Force.
This is an industry that needs to be looked at a lot more closely, because we’re an aging population. I think there needs to be some policies and regulations in place to protect them.
Sen. Patricia Billie Miller
“The confusion about thedifferent spectrum of services provided under the home care umbrella is a huge issue,” she added. “It’s confusing for people who work for the state, so think about how confusing it is for consumers. So I think the real challenge as a state is: Does it make sense the way this is all happening right now, all chopped up, among state agencies?”
Several HCA owners testified in favor of the bill, particularly the need for more training and transparency by all HCAs.
“The demand for in-home care has never been greater. Not only is their home where they want this care to occur, but this is the most cost-efficient setting,” said Guy Tomasso, owner of Lifetime Care in Guilford.
“This bill will ensure that all registered homemaker companion agencies will be held to the same standards,” he said. “As providers of this care, we must be accountable to those who have placed their trust [in us] and have peace of mind.”
Tomasso specifically mentioned mandated training programs and several important upgrades, such as “person centered care plans.”
Task force co-chairwoman Anne Foley was a state employee 15 years ago when the original language for registration for HCAs was established, she said.
“We didn’t have any kind of oversight at all over homemaker companion agencies, and we decided that we needed some kind of structure in order to protect the consumers and clients of these services,” Foley said.
“But, clearly, 15 years is a long time, and things have changed demographically, things have changed structurally, and I think it’s just really the right time to relook at the entire system,” she added.
The biggest change is the sheer number of HCAs, which have tripled, while the size of the DCP unit that handles complaints and conducts audits has shrunk, according to DCP officials.
Over the last 10 years, the number of HCAs has grown from 308 to 903, and “we’re still dealing with minimal staffing and in statutory and regulatory frameworks that are much different from when this started,” Foley added.
Home care options vary
With the state placing more money and emphasis on keeping people out of nursing homes, there are several options available for aging in place, according to Tracy Wodatch, the president of the Connecticut Association for Healthcare at Home.
The highest level of care would be by a licensed home health care professional. Wodatch said this is someone who has the ability to administer medications, including shots if necessary, and would be needed by anyone with long-term health concerns. Consumers must have an order from a health care provider to access these services.
The field includes everyone from registered nurses to physical therapists to speech therapists. They are licensed by the Department of Public Health and must follow strict regulations, Wodatch said.
Tracy Wodatch Arielle Levin Becker / CTMirror.org
“The other level of care is what we would call long-term services and supports,” she said. “Somebody doesn’t really have a medical diagnosis, maybe they have some dementia, they can’t live alone, but they’re certainly able to get up and about, they might not remember to take their medications, they might not remember to take a shower or eat. So they really need a support system in there to help them with a structured day.”
At this level, she said, residents on state Medicaid waivers can hire a personal care aide, or PCA, to help them with daily tasks.
Many PCAs are represented by SEIU 1199 New England. Their numbers have grown from fewer than 6,000 in 2012 to about 11,000 now.
The PCAs are listed in a binder of printed pages created by the contractor hired by the state Department of Social Services to handle payroll, but the information that is available is often outdated, and there is no searchable online database.
“A lot of it is through word of mouth. I’ve seen people posting for PCAs on grocery store bulletin boards. I’ve heard of people posting for them on Craigslist. It’s all over the map,” said Diedre Murch, home care director with SEIU 1199 New England, the state’s largest health care workers union, which represents many of the PCAs.
PCAs are not licensed by the state, and while they are not authorized to dispense medications or provide medical services, such as wound care, many end up doing just that, Murch said.
“We often think of home care as kind of like the wild, wild west,” Murch said. “There’s a lot of gray area in home care. Technically they’re not doing medical tasks, but it’s not uncommon to have a PCA talk about removing suctioning tubes.”
“There are certainly a pretty large number of caregivers who provide some pretty advanced care to people with very complex medical needs,” she added.
We often think of home care as kind of like the wild, wild west.
Diedre Murch, SEIU 1199 New England
The third level of care is what Wodatch refers to as “agency-based, long-term services and supports.” Those are usually provided by a homemaker companion agency, she said.
All homemaker companion agencies must be registered with DCP, but their workers are not licensed by the state.
Just over one-third of the HCAs participate in a state-funded Medicaid waiver program called the Connecticut Home Care Program for Elders. Those agencies are subject to some additional quality checks and audits from a fiscal intermediary hired by the state.
The different state agencies involved, varying licensing requirements and a dearth of accurate information make the system difficult to navigate, advocates say, especially for consumers facing family emergencies.
“A lot of people come into needing home care services at a moment of crisis in their life and find it really confusing to understand. If there’s a problem, do I call DPH? Do I call DCP? And it feels very unclear,” AARP Executive Director Anna Doroghazi said.
Anna Doroghazi, policy and advocacy director for the AARP in Connecticut, far right, talks to Antonio Matta, architect at Goodwin University. Doroghazi said there aren’t enough workers in the home health agencies compared to the demand. “We know that the need for it is going to grow and grow as we have an aging population,” she said. Yehyun Kim / ctmirror.org
“It’s a very, very disjointed consumer experience,” Doroghazi said. “I get a lot of very upset, very surprised calls from consumers who are saying, ‘I didn’t realize there were different standards for background checks between my homemaker companion and my personal care aide like, why, why is this happening? How do I fix this?’”
‘Keeping my father hostage’
Constantine Milonas was frustrated having to deal with multiple agencies when he discovered his father’s personal care aide had moved into his apartment and wouldn’t leave.
Milonas said he was stunned when he walked into the emergency room at St. Mary’s Hospital in March of 2018 to see the woman who had been hired as his father’s PCA telling doctors they were married.
“I was shocked when the doctor told me that ‘Ms. Milonas’ had informed them she was in a romantic relationship with my father, so they should inform her of all medical decisions,” he said.
Her name was Kelly Jennine Peters, and she had been hired through a company called Quality Home Care to be a personal care aide for 79-year-old James Milonas, who had suffered a stroke a few years before.
James Milonas died a few weeks after he was brought to St. Mary’s, but the family’s troubles with Peters were far from over, according to the complaint the family’s attorney filed with the state. The aide refused to allow them into the apartment or turn over the keys, the attorney wrote, and said she had moved in when they became a couple.
We don’t know what happened to this woman who took over this man’s house, but neither does the state, and she could be doing it all over again elsewhere and they wouldn’t know.
attorney Mary Alice Loughlin
Milonas said he tried multiple times to gain entry to his father’s apartment and get the keys back but was unsuccessful. He then hired attorney Mary Alice Loughlin, and she filed complaints with the HCA, state Office of Elderly Protective Services and, finally, DCP.
“There was nothing I could do. I had the power of attorney for my father, and I couldn’t even get into his apartment, and I couldn’t get anybody to help me out,” Milonas said.
Eventually, Loughlin, with the assistance of Waterbury police, did get the family into the apartment and removed some of the father’s possessions.
DCP opened an investigation in the spring of 2018 and found that the agency fired Peters before the state could fully investigate.
Quality Home Care could not be reached for comment. But the DCP investigative file contains a letter thatQuality Home Care President Miguel Rosado wrote to Peters informing her that she “was no longer employed by Quality Home Care effective immediately.”
“As you know, you never have been and are not now authorized to occupy the residence of James Milonas,” Rosado wrote. “You were not assigned to any oversight position and have never been entitled to occupy the residence.”
Rosado ended the letter warning Peters “she was not permitted by the Milonas family from attending the wake, funeral of graveside service.”
Peters could not be reached for comment.
When DCP finished its investigation in October 2019, the company was ordered touse specific language in employee contracts having them certify they don’t have criminal records.
“The state doesn’t have the resources to adequately inspect, oversee and police the home care field,” said Loughlin, the family’s attorney. “We don’t know what happened to this woman who took over this man’s house, but neither does the state, and she could be doing it all over again elsewhere and they wouldn’t know.”
Growing problem
DCP Deputy Commissioner Pamela Brown, who oversees the agency’s investigative units, said in an interview with the CT Mirror that the agency randomly audits about two HCAs a month. The department has one supervisor and two investigators dedicated to investigating complaints against HCAs.
Brown said in 2019 there were 81 complaints filed with DCP; the number rose to 120 in 2020 and fell back to 73 in 2021, with 64 complaints in 2022.
A review of these complaints shows that many are either billing issues, false advertising allegations against a company, or accusations that apersonal care aide has left someone home alone.
“Advertising is one of our larger issues, where as someone may say they offer home health services when they’re actually a homemaker companion, or they claim they offer a higher level of service for dementia care or Alzheimer’s care when their staff hasn’t been trained in those areas,” Brown said.
Complaints of fraud or abuse are passed onto law enforcement agencies or, in cases of just fraud, to the banks involved. Given the number of complaints compared to the number of staff, the agency has no choice but to pass on many investigations.
“We can always use more staff there. I mean, this is a growing issue,” Brown said. “Investigating these complaints is going to take time, especially when you are dealing with someone’s finances.”
She acknowledged the state relies on the agencies to police themselves because the state just doesn’t have the manpower to do so.
“There are over 900 home companion agencies registered in Connecticut right now. Some of these individuals are working in someone’s home either 24 hours a day, or 12 hours a day, and I believe if we had more supervision site visits from these agencies themselves, that would prevent a lot of the problems,” Brown said.
Brown also testified before the task force and emphasized the department’s concern that many HCAs are falsely advertising services they cannot provide.
‘I figured, what the heck’
Regina Stankaitis, 69, knew she was going to need some assistance at her Cromwell home after surgery and decided to contact “Care Giving by Kathy” — the homemaker companion agency recommended by her doctor’s secretary.
But Sally Douglas lasted barely a week as her aide before Stankaitis, feeling threatened by her new aide, asked her to leave. It wasn’t until about a month later, when her bank contacted her about a $4,000 check for a paint job at an apartment in Rocky Hill, that she realized something was wrong. Police later determined Douglas was living in the apartment.
She went to her bureau and discovered that the checkbook she kept hidden in her underwear drawer was missing. She called her sister, andthey filed a complaint with the Cromwell police.
“I figured if someone from the doctor’s office was recommending them, then I figured what the heck, they must be OK,” Stankaitis said. “But boy, was I wrong.”
The police investigation showed that Douglas, who only worked for the agency for one week, also had used Stankaitis’ credit card to purchase about $2,300 worth of furniture for the Rocky Hill apartment. Police also discovered thatDouglas had a previous criminal record that included assault, criminal trespassing and threatening, and had been charged with third-degree larceny only a few months before she became Stankaitis’ personal care aide.
Care Giver by Kathy Business Manager Ciara Lundell said she couldn’t discuss an employee but noted, “Sally Douglas was only an employee here from Aug. 10 to Aug. 18th.”
Police charged Douglas in March 2022 with third-degree larceny and second-degree identity theft. Her case is still pending in Middlesex Superior Court, and Stankaitis has attended all 14 court dates, with the next onescheduled for May 4. Attempts to reach Douglas’ attorney, Richard Silverstein of New Haven, were unsuccessful.
“I want to see this through and make sure she is held accountable so she can’t do this to anyone else,” Stankaitis said.
Yehyun Kim / ctmirror.org
“CT’s Elder Care Reckoning” is a four-part series about Connecticut’s aging population and the challenges in finding ways to care for people.
Want to share what you know? Send your tips to Jenna Carlesso at jcarlesso@ctmirror.org or Dave Altimari at daltimari@ctmirror.org.
PROJECT CREDITS
Reporting: Dave Altimari, Jenna Carlesso Photography: Yehyun Kim Data visualization: Katy Golvala Editing: Elizabeth Hamilton, Stephen Busemeyer, Keila Torres Ocasio Social media: Gabby DeBenedictis, Nicole McIsaac Web development: Kyle Constable
Cough medication tainted with ethylene glycol that killed at the very least 19 kids in Uzbekistan in late December 2022 has after again unveiled lax oversight and regulation of pharmaceutical firms based mostly in India.
That preventable tragedy, which consists of solutions produced by Marion Biotech, based in Noida, India, echoes previously conditions. In the summer of 2022, at the very least 70 young children in Gambia died from kidney failure immediately after applying cough drugs built by India-primarily based Maiden Pharmaceuticals that contained ethylene glycol and diethylene glycol, poisonous chemical substances typically utilized in producing as dissolving brokers that can problems the heart, mind, and kidneys.
India has experienced plenty of time to master about — and management — tainted prescription drugs, but hasn’t performed so. The outbreak in Gambia turned general public just times soon after a new e book, “The Truth of the matter Tablet: The Myth of Drug Regulation in India,” was revealed. The e book, published by Dinesh S. Thakur, a former pharmaceutical govt whose revelations of fraud led to a enormous and prosperous U.S. Division of Justice lawsuit towards Indian drugmaker Ranbaxy in 2013, and his colleague Prashant Reddy T, a law firm specializing in intellectual assets and drug regulatory legislation, opens with descriptions of five former episodes of men and women dying just after employing cough drugs.
ad
I spoke with Thakur and Reddy about what ails drug regulation in India, and why it demands to be mounted. Our discussion has been flippantly edited for duration and clarity.
How popular is the trouble of ineffective or unsafe or dangerous medicine currently being made by Indian pharmaceutical providers?
advertisement
Thakur: It is considerably far more common than it really should be. We wrote about five episodes of fatalities thanks to poisoning by medications made with diethyl glycol that go again as far as 1972. At minimum 90 men and women, mainly children, died, however that is unquestionably an undervalue due to the fact this form of poisoning can be difficult to diagnose. All of these have been documented to drug regulators, but it retained going on. And it goes over and above cough syrup produced with diethylene or ethylene glycol: An adulterated batch of propofol, a sedative employed in medical procedures, killed five people at a hospital in Chandigarh, a city in north India. For the duration of the pandemic there was a verified news report of generic Remdesivir created by an Indian pharmaceutical enterprise that examined good for bacterial endotoxins.
Unsafe medications are just the tip of the iceberg. Substandard or ineffective medications might be an even bigger trouble.
Reddy: India has arrive to be regarded as the pharmacy for the building environment. Some of the medication it makes are utilised in India or bought to nicely-regulated marketplaces in the United States and European Union. But India exports a higher volume of medications, largely generic medicine, to inadequately regulated marketplaces in Southeast Asia, Africa, and Latin The united states. Couple of of these countries can mail inspectors to Indian manufacturing crops to assure that their procedures are safe and sound, or don’t have the sources to examination batches of medication when they arrive in their nations, issues the U.S. and Europe can do. So people nations around the world are totally dependent on Indian drug regulators carrying out their career. If they really don’t do their career, people can die.
Is this a tough issue to stop?
Thakur: It shouldn’t be. The very first mass poisoning with diethylene glycol occurred in the United States in 1937 with a “wonder drug” antibiotic named sulfanilamide, designed by a U.S. business referred to as S.E. Massengill. The 1st deaths have been noted within a handful of times of the drug moving into the marketplace and, in spite of a frantic recall, 105 individuals died. That episode provoked an overhaul of the Federal Foodstuff, Drug, and Cosmetics Act with an increased emphasis on security. The U.S. has not experienced an additional mass poisoning with DEG due to the fact.
But the similar detail hasn’t happened in India simply because of how the method of oversight was set up, and how it has been managed given that.
Reddy: In the U.S., there is a solitary regulator: the U.S. Meals and Drug Administration. It is accountable for overseeing the development and acceptance of new medicine, and earning absolutely sure that all medicine are manufactured appropriately. Its oversight even extends to manufacturing crops in India and elsewhere that are generating medicines for the U.S. current market. In distinction, India has a number of regulators. The Central Prescription drugs Common Manage Organisation, which is section of the Ministry of Health, is billed with approving new medications. But at the time a drug has been authorized, oversight of its production — and the conclusion to approve generic variations — is in the arms of the regulator in each and every of India’s 28 states.
Right after a new drug has been on the marketplace for 4 a long time, any competitor can utilize to any state in India for a license to make a generic model. At the time the software has been authorised by the condition, the organization is fantastic to go. If the product fails screening in a various point out, drug inspectors in that state can initiate felony prosecution of the company, but they can’t examine the company’s producing facility devoid of the authorization and cooperation of the point out that licensed the facility.
In other words and phrases, India has a technique that is fragmented and unwieldy, in which distinctive sections of the regulatory framework are not cooperating, and conversing to every single other, or sharing facts. The country doesn’t even have a easy database of all the medicines that have been approved by unique states.
You wrote that “The Govt of India is a lot more fascinated in propping up the Indian pharmaceutical business — the only production good results story for India to showcase on the world wide phase — and towards this close it will constantly resist tightening the regulatory screws.” That’s a rather bleak view.
Thakur: And it’s regrettable, due to the fact if the pharma sector in India did the correct things — creating very good production processes part of the standard way to do company, inspecting manufacturing plants, and prosecuting wrongdoers — it has the prospective to mature 10 instances more substantial.
It sounds like a 3-pronged difficulty: challenging or nonexistent regulation lousy actors, folks who are chopping corners and not applying excellent producing processes and failure to look into or prosecute. Can you elaborate on the latter?
Thakur: Here’s an instance: In 2013, the Drug Tests Laboratory in Chennai discovered that supplements that have been supposed to include glipizide, made use of to address diabetic issues, did not contain that drug but a further diabetic issues drug, glibenclamide, which need to not be made use of as a substitute for glipizide with out tips from a medical doctor. More than fifty percent a million tablets had been bought to a federal government business accountable for obtaining and distributing prescription drugs to government-operate hospitals throughout the state of Tamil Nadu. It is feasible that the substitution was intentional, considering that glipizide fees 4 occasions a lot more than glibenclamide.
A legal criticism was filed from that manufacturer, Alfred Berg & Business, in 2014. Yet in accordance to our analysis, as of March 2022, the case experienced not proceeded to demo irrespective of the court docket having issued non-bailable warrants for the arrest of the executives in charge of managing the business. It is the duty of the state law enforcement to execute the warrants. For some rationale, not recognised to us, the warrants had been but to be executed as of 2022.
Reddy: The relationship among the Indian pharma business, regulators, and prosecutors is a telling case in point of regulatory seize — when regulatory businesses have come to be dominated by the industries or interests they are billed with regulating. When the procedure refuses to implement the law, and the message to the business and regulators is “Let’s not prosecute these forms of cases,” that sends a signal that the regulator is a lot more intrigued in the growth of the pharma industry than in protecting general public wellness.
What prompted you to publish “The Truth Capsule?”
Thakur: Immediately after the Ranbaxy settlement in 2013, there was some interest on the Indian pharma sector, both of those globally and nationally. But then regulators and prosecutors went again to what they experienced been carrying out right before that. So we worked for a lot more than a yr to place jointly what we considered was a meaningful pathway for reforming drug regulation in India. We introduced it to the Minister of Overall health, but it did not go any where.
We then tried a distinctive solution: In India, an personal or group can file a petition on behalf of the public as very long as all those filing would not individually profit from a resolution of the circumstance. The judges who reluctantly listened to our public interest litigation known as it an “academic issue” and compelled us to withdraw the petition.
Mainly because persons in India, and all those in nations acquiring pharmaceuticals made in India, don’t recognize the magnitude of the problem — rightly so, simply because there’s been very little reporting or educational composing on this challenge in India — we resolved it would be a fantastic plan to place our research into a e-book and put it out there so there’s a additional educated public dialogue on some of the challenges that wanted to be fixed.
Supplied how protecting India appears to be of its pharmaceutical business, what is it been like due to the fact you revealed the guide?
Reddy: The governing administration hasn’t spoken about the ebook, but it did not respect what we stated right after the deaths in Gambia became information. We built some statements in an interview to the press that have been critical of the nationwide regulator — the Central Medications Typical Command Organisation — and the Ministry of Health, which also plays a major part in drug regulation.
In reaction, we gained a menacing lawful discover from the national drug regulator on a Saturday evening, 30 minutes prior to our e book was set to start in Delhi. It was not clear about what regulation we experienced violated, but threatened us with undermining “trust and religion of the community in the Indian Drug Regulatory system” — which isn’t a criminal offense.
Thakur: It’s a webpage ideal out of their playbook. A several a long time ago, Amir Attaran, a professor of law and medicine at the College of Ottawa, and several colleagues done a examine on the high quality of India-produced antibiotic and tuberculosis medication sold in Africa, India, and five mid-income international locations outside of Africa. They established that Indian firms sold poorer-quality medicines in Africa than in other international locations. The govt of India threatened to sue the authors and their funders for defamation.
The same factor took place when Katherine Eban’s exposé of India’s generic drug sector, “Bottle of Lies,” was released. The countrywide regulator wrote to the Ministry of Wellbeing, asking it to acquire legal action in opposition to Eban.
Rather of attempting to solve the trouble, the government’s very first response is, “How do you shut these people up?”
Say up coming 7 days you get a phone from Narendra Modi, India’s primary minister, asking you two to revamp drug regulation in India. Where would you start?
Thakur: The to start with and best thing we would advocate is transparency. Make the working of the Central Prescription drugs Conventional Handle Organisation and all condition drug controllers more clear. Publish all inspection reports of pharmaceutical producers inside 30 days of the inspection. Publish in depth minutes of meetings of all statutory and advisory committees on any drug acceptance or licensing community in a couple months. Make a national database of all regulatory actions taken against every single pharmaceutical manufacturer and make it general public. That would be an fantastic begin.
Overseeing Medicare’s new authority to negotiate costs of the country’s greatest-investing medicine is amid the best priorities for lawmakers as Congress returns to Washington.
Democrats did superior than predicted in the midterm elections, creating it less most likely Republicans will follow as a result of on threats to repeal parts of the Biden administration’s landmark Inflation Reduction Act, plan analysts say. But lawmakers and sector teams system to place tension on the Medicare agency as it prepares to start off negotiating drug prices, such as by holding congressional oversight hearings and pursuing clarity on the law’s provisions.
“The industry as a complete is at an inflection level,” said Duane Wright, a senior investigation analyst at Bloomberg Intelligence.
“They’ll be aiming a lot of their firepower at the regulatory method to condition the regulation, although concentrating legislative initiatives on other priorities,” which include transparency all over pharmacy advantage managers—the entities that deal with drug protection for health insurers, huge companies, and other people, he said.
Generic and biosimilar competitiveness is one more space likely to get focus from Congress as lawmakers find to go beyond the issues resolved in the IRA (Community Regulation 117-169). Some lawmakers prepare to reignite their press to reduce what People across overall health insurance plan designs fork out for insulin.
Sen. Bernie Sanders (I-Vt.), who is poised to choose around the Senate Wellbeing, Education and learning, Labor and Pensions Committee, expressed optimism on what customers of his caucus could get accomplished with Democrats keeping 51 seats in the Senate—an improvement from the preceding 50-50 break up. Sanders has pointed to prescription drug rates as a important priority for him in the new calendar year.
“We can go a great deal more aggressively in passing laws to defend performing families,” he said in an interview.
‘A Ton of Hearings’
As the IRA is applied, Congress’ role will generally be concentrated on oversight, with “a lot of hearings on how CMS is continuing with implementation,” mentioned Mark E. Miller, government vice president of overall health treatment at the philanthropy-funded Arnold Ventures.
Under the regulation, Medicare will commence position the most highly-priced medicines centered on total expenditures, and enter negotiations with the suppliers to determine most good charges. The first 10 Medicare Element D drugs will be chosen for the Drug Value Negotiation Program by Sept. 1, 2023, primarily based on expending info for the 12-month period from June 1, 2022 to May 31, 2023.
The IRA also allows Medicare to situation rebates to drug suppliers who elevate their rates speedier than the level of inflation. The law sets a $2,000 yearly cap on Medicare beneficiaries’ out-of-pocket pharmacy charges beginning in 2025, and as of Jan. 1, Us residents enrolled in Medicare will not want to pay back more than $35 per month on insulin.
Industry and policy analysts nevertheless have concerns on how the IRA will be carried out. Pharmaceutical companies still left a personal assembly with CMS officials in December with no new responses on the rate negotiations, together with whether the medicine the CMS selects will be primarily based on net or gross sales.
The agency has so considerably declined to comment on its prepared technique.
Some drug field associates have identified as for tweaks or specialized variations to the law, including boosting the variety of yrs of protection smaller-molecule medications have from authorities negotiation. Smaller molecule drugs—which have customarily produced up most of the market—are exempt from this process until eventually 9 yrs after their approval date. More sophisticated biologics are exempt till 13 decades soon after approval.
An industry supply said a option to this would need to have to appear from Congress, and that businesses would be doing work to thrust for that relocating forward.
But with Democrats top the Senate and a keeping a appreciable existence in the Household, “legislative choices for repeal or delay seem off the table,” and the Biden administration probable will not “entertain any alterations,” Wright explained.
Drug Competitiveness
Republicans and pharmaceutical teams have warned that firms will have much less incentive to develop new goods, including generics and biosimilars—lower-expense versions of biologics—while hoping to contend with federal government-negotiated drug prices pursuant to the IRA.
They argue that market competitiveness, not authorities intervention, ought to aid push down the price of medicines.
Rep. Cathy McMorris Rodgers (R-Wash.), incoming chair of the Household Strength and Commerce Committee, reported in an emailed statement that functioning “to expose the hurt performed to the generic drug field by the IRA” is a single of her crucial priorities.
Section of encouraging generic improvement will require addressing sure patent methods by brand name-title drugmakers that allegedly limit competitiveness, explained Anna Kaltenboeck, head of the drug pricing apply at healthcare consulting company ATI Advisory, who till October served as a senior well being coverage adviser on the Senate Finance Committee.
“There are situations in which these reference products have patent-thickened on their own to a quite higher diploma and make it very challenging for biosimilars to enter the current market in just a sensible time to carry down costs,” she said. In the drug market, patent thickets refer to when model-title makers look for various patents for minimal variants on a single solution to lengthen the period of time that they are secured from competition.
PBM Transparency
1 of the drug industry’s major issues from the IRA is that it doesn’t handle what they see as the root bring about of higher drug costs—pharmacy profit supervisors and the rebates and charges they collect from drug makers and pharmacies.
Unbiased pharmacies say PBMs’ current integration with retail pharmacies and overall health options has steered sufferers absent from their corporations, though drug producers argue that getting to shell out PBMs rebates and savings outcomes in greater first listing prices.
The Pharmaceutical Care Administration Affiliation, the main PBM trade team, claims they have not minimal the wholesome progress of the independent pharmacy market, and that PBMs get the job done to provide savings to clients.
Lawmakers, specially Republicans, have proposed legislation that could resurface in the new Congress. A bill (S. 4293) from Sen. Chuck Grassley (R-Iowa) would prohibit PBMs from training spread pricing, or charging wellness designs a lot more for a drug than they reimburse to pharmacies. It would also require PBMs to move 100{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of rebates to wellness programs, and authorize the Federal Trade Commission and point out lawyers common to search for civil penalties for violations of FTC mandates.
PBMs are a prime precedence for McMorris Rodgers in the new Congress, precisely investigating if “PBMs are retaining lower charge prescription drugs off formularies in favor of better rebated brand medicine.”
JC Scott, PCMA’s president and CEO, reported in an job interview that the team would “have terrific worry with legislation that would just take away possibilities for companies and other system sponsors to layout their drug rewards in the way to very best meet the distinctive requires of their patient populations.”
Insulin Expenses
The insulin cap incorporated in the IRA did not go as much as some lawmakers would have preferred in operating towards obtaining broader discounts for clients who count on the drug.
Sen. Jeanne Shaheen (D-N.H.), together with Sen. Susan Collins (R-Maine), introduced a monthly bill in the final Congress to restrict to $35 for every thirty day period what persons with non-public insurance policy pay for the diabetes drugs. The monthly bill would also make alterations to rebate procedures aimed at lowering the true price tag of insulin.
Shaheen told Bloomberg Federal government in December that she planned to renew her proposed insulin cap with Collins in the subsequent Congress, incorporating that she thinks this could see bipartisan motion.
In general, the new legislative session provides an possibility for a greater comprehension of how drug prices are established and how to overcome increasing client prices, Scott stated.
“There’s a ongoing bipartisan desire in challenges about prescription drug affordability, and a whole lot of that will be an option for dialogue, training, and engagement,” he claimed.
